Originally Posted by Anonymous
Look the non-steroidal side of the combo is not the FDA's favorite. The steroidal side of the combo was never a big seller. What part of that combo was going to make a blockbuster. S-P knew that this combo was no great shakes. I don't know what Merck was thinking. Over the last 6 years I must tell you that S-P's reputation with the FDA is far better than Merck's. The number of Old Merck's shocking rejections from the FDA is stunning. Half-baked applications from legacy Merck coupled with not particularly interesting products from S-P and the merge company all adds up to some grim days ahead.
It might be better but that is not saying much. SP was on their **** list for quite a while. It was what held up Clarinex for quite a while. The FDA figured- why reward a poor performer by giving them the approval when they couldn't even get Proventil to be problem-free. Merck "merged" with this and now we all will pay the price although Merck pays the higher price because they "bought" SP. SP heads will always have a good laugh about this at Merck's expense.